Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Angiogenesis”

272 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 272 results

Testing effectiveness (Phase 2)Looking for participantsNCT06662006
What this trial is testing

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Who this might be right for
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Not applicableStudy completedNCT02639676
What this trial is testing

Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development

Who this might be right for
Preeclampsia
Indiana University 292
Testing effectiveness (Phase 2)Ended earlyNCT00549328
What this trial is testing

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 14
Testing effectiveness (Phase 2)Study completedNCT00602199
What this trial is testing

ABT-510 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 42
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Early research (Phase 1)Study completedNCT00747734
What this trial is testing

MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Study completedNCT00460603
What this trial is testing

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Pfizer 187
Early research (Phase 1)UnknownNCT01341834
What this trial is testing

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

Who this might be right for
Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour
National Cancer Centre, Singapore 49
Not applicableStudy completedNCT00121134
What this trial is testing

Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Harold J. Burstein, MD, PhD 164
Testing effectiveness (Phase 2)Ended earlyNCT00694200
What this trial is testing

Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04069273
What this trial is testing

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerAdenocarcinoma
Harry H Yoon 58
Not applicableLooking for participantsNCT07293819
What this trial is testing

Comprehensive Assessment of First Trimester Pregnancy Loss

Who this might be right for
Miscarriage in First Trimester
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 225
Testing effectiveness (Phase 2)Ended earlyNCT00462865
What this trial is testing

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Who this might be right for
Breast Cancer
Brown University 18
Not applicableStudy completedNCT05540145
What this trial is testing

Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Large-scale testing (Phase 3)Looking for participantsNCT06264531
What this trial is testing

Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations

Who this might be right for
Cerebral AV Malformation
Fondation Ophtalmologique Adolphe de Rothschild 54
Testing effectiveness (Phase 2)Study completedNCT03577743
What this trial is testing

Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast CancerSafety IssuesEfficacy
Assiut University 54
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05859217
What this trial is testing

Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

Who this might be right for
Lung CancerNSCLC Stage IVMetastatic NSCLC - Non-Small Cell Lung Cancer+1 more
Jun Zhang, MD, PhD 40
Testing effectiveness (Phase 2)UnknownNCT04446091
What this trial is testing

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Who this might be right for
Colorectal Cancer
Zhejiang Cancer Hospital 40
Next Page